| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |